Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 128

1.

Pathways to the elimination of Hepatitis C: Prioritising access for all.

Pedrana AE, Sacks-Davis R, Doyle JS, Hellard ME.

Expert Rev Clin Pharmacol. 2017 Sep 25. doi: 10.1080/17512433.2017.1383894. [Epub ahead of print] No abstract available.

PMID:
28942660
2.

Reaching hepatitis C virus elimination targets requires health system interventions to enhance the care cascade.

Scott N, Doyle JS, Wilson DP, Wade A, Howell J, Pedrana A, Thompson A, Hellard ME.

Int J Drug Policy. 2017 Sep;47:107-116. doi: 10.1016/j.drugpo.2017.07.006. Epub 2017 Aug 7.

PMID:
28797497
3.

New hepatitis C antiviral treatments eliminate the virus.

Doyle JS, Thompson AJ, Higgs P, Stoove M, Dietze PM, Hellard ME.

Lancet. 2017 Jul 22;390(10092):358-359. doi: 10.1016/S0140-6736(17)31817-2. Epub 2017 Jul 7. No abstract available.

PMID:
28689663
4.

Re-examining blood donor deferral criteria relating to injecting drug use.

Quinn B, Seed C, Keller A, Maher L, Wilson D, Farrell M, Caris S, Williams J, Madden A, Thompson A, Pink J, Hellard ME.

Int J Drug Policy. 2017 Oct;48:9-17. doi: 10.1016/j.drugpo.2017.05.058. Epub 2017 Jun 27.

PMID:
28666205
5.

Young Australians' use of pornography and associations with sexual risk behaviours.

Lim MSC, Agius PA, Carrotte ER, Vella AM, Hellard ME.

Aust N Z J Public Health. 2017 Aug;41(4):438-443. doi: 10.1111/1753-6405.12678. Epub 2017 Jun 29.

PMID:
28664609
6.

Anorectal swabs as a marker of male-to-male sexual exposure in STI surveillance systems.

Ampt FH, El Hayek C, Agius PA, Bowring AL, Bartnik N, VAN Gemert C, Fairley CK, Chow EPF, Bradshaw CS, Stephens N, Lim MSC, Hellard ME.

Epidemiol Infect. 2017 Sep;145(12):2530-2535. doi: 10.1017/S095026881700098X. Epub 2017 May 22.

PMID:
28528588
7.

Correlates of sexually transmissible infection testing among a sample of at-risk young Australians.

Douglass CH, Vella AM, Hellard ME, Lim MSC.

Aust J Prim Health. 2017 Apr 20. doi: 10.1071/PY16115. [Epub ahead of print]

PMID:
28424143
8.

Resumption of injecting drug use following release from prison in Australia.

Winter RJ, Young JT, Stoové M, Agius PA, Hellard ME, Kinner SA.

Drug Alcohol Depend. 2016 Nov 1;168:104-111. doi: 10.1016/j.drugalcdep.2016.08.640. Epub 2016 Sep 8.

PMID:
27635997
9.

A nurse-led intervention improved blood-borne virus testing and vaccination in Victorian prisons.

Winter RJ, White B, Kinner SA, Stoové M, Guy R, Hellard ME.

Aust N Z J Public Health. 2016 Dec;40(6):592-594. doi: 10.1111/1753-6405.12578. Epub 2016 Oct 23.

PMID:
27774690
10.

Exploring attitudes towards sexting of young people: a cross-sectional study.

Lim MS, Vella AM, Horyniak DR, Hellard ME.

Sex Health. 2016 Oct 7. doi: 10.1071/SH16029. [Epub ahead of print]

PMID:
27712613
11.

"I am yet to encounter any survey that actually reflects my life": a qualitative study of inclusivity in sexual health research.

Carrotte ER, Vella AM, Bowring AL, Douglass C, Hellard ME, Lim MS.

BMC Med Res Methodol. 2016 Jul 27;16:86. doi: 10.1186/s12874-016-0193-4.

12.

Quality of Life and Social Functioning during Treatment of Recent Hepatitis C Infection: A Multi-Centre Prospective Cohort.

Doyle JS, Grebely J, Spelman T, Alavi M, Matthews GV, Thompson AJ, Dore GJ, Hellard ME; ATAHC Study Group.

PLoS One. 2016 Jun 29;11(6):e0150655. doi: 10.1371/journal.pone.0150655. eCollection 2016.

13.

Water, Sanitation, and Hygiene Facilities and Hygiene Practices Associated with Diarrhea and Vomiting in Monastic Schools, Myanmar.

Weaver ER, Agius PA, Veale H, Dorning K, Hlang TT, Aung PP, Fowkes FJ, Hellard ME.

Am J Trop Med Hyg. 2016 Aug 3;95(2):278-87. doi: 10.4269/ajtmh.15-0290. Epub 2016 Jun 20.

14.

Treatment scale-up to achieve global HCV incidence and mortality elimination targets: a cost-effectiveness model.

Scott N, McBryde ES, Thompson A, Doyle JS, Hellard ME.

Gut. 2017 Aug;66(8):1507-1515. doi: 10.1136/gutjnl-2016-311504. Epub 2016 Apr 12.

PMID:
27196586
15.

A systematic review of community based hepatitis C treatment.

Wade AJ, Veronese V, Hellard ME, Doyle JS.

BMC Infect Dis. 2016 May 16;16:202. doi: 10.1186/s12879-016-1548-5.

16.

Mental Health and Associated Sexual Health Behaviours in a Sample of Young People Attending a Music Festival in Melbourne, Victoria.

Carrotte ER, Vella AM, Hellard ME, Lim MS.

Community Ment Health J. 2016 Nov;52(8):1082-1088. Epub 2016 Jan 6.

PMID:
26738496
17.

HIV infection and hepatitis C virus genotype 1a are associated with phylogenetic clustering among people with recently acquired hepatitis C virus infection.

Bartlett SR, Jacka B, Bull RA, Luciani F, Matthews GV, Lamoury FM, Hellard ME, Hajarizadeh B, Teutsch S, White B, Maher L, Dore GJ, Lloyd AR, Grebely J, Applegate TL.

Infect Genet Evol. 2016 Jan;37:252-8. doi: 10.1016/j.meegid.2015.11.028. Epub 2015 Nov 26.

18.

The Cascade of Care for an Australian Community-Based Hepatitis C Treatment Service.

Wade AJ, Macdonald DM, Doyle JS, Gordon A, Roberts SK, Thompson AJ, Hellard ME.

PLoS One. 2015 Nov 12;10(11):e0142770. doi: 10.1371/journal.pone.0142770. eCollection 2015.

19.

Cost-effectiveness of treating chronic hepatitis C virus with direct-acting antivirals in people who inject drugs in Australia.

Scott N, Iser DM, Thompson AJ, Doyle JS, Hellard ME.

J Gastroenterol Hepatol. 2016 Apr;31(4):872-82. doi: 10.1111/jgh.13223.

PMID:
26514998
20.

Global policy and access to new hepatitis C therapies for people who inject drugs.

Doyle JS, Aspinall EJ, Hutchinson SJ, Quinn B, Gore C, Wiktor SZ, Hellard ME.

Int J Drug Policy. 2015 Nov;26(11):1064-71. doi: 10.1016/j.drugpo.2015.05.008. Epub 2015 Jun 2. Review.

PMID:
26118794

Supplemental Content

Loading ...
Support Center